/

SOPH

SOPHiA GENETICS SAAfter hours

7.09−0.13 −1.80%USD

NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 7.09 0.00%

Open

7.20

Prev close

7.22

Day range

7.057.33

52-week range

3.758.98

Volume

271.19K0.49×

Mkt cap

603.56M

P/E ttm

—

Fwd P/E

-14.18

EPS ttm

-1.16

Div yield

0.00%

Earnings

Aug 4, 2026

From 52w high

−21.05%

Price Chart

Yahoo Finance · delayed

SOPHOct 13, 2026O 7.20H 7.32L 7.05C 7.09−0.13 (−1.80%)Vol 271.19K

SMA 507.92
SMA 2005.79

1Y change +69.62% since Oct 10, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

SOPH SOPHiA GENETICS SA · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −3.93%
1 month: −9.91%
3 months: +24.82%
6 months: +42.94%
Year to date: +51.82%
1 year: +75.50%

Valuation & ownership

Market cap: 603.56M
Enterprise value: 568.78M
P/E (ttm): —
Forward P/E: -14.18
PEG ratio: —
Price / book: 7.26
Price / sales (ttm): 7.00
EV / EBITDA: -7.93
EPS (ttm): -1.16
EPS (forward): -0.5000
Beta (5y monthly): 0.95
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 85.13M
Float: 65.45M
Short % of float: 1.40%
Short ratio (days): 1.67
Held by insiders: 6.65%
Held by institutions: 62.33%
Avg volume (3m): 553.88K
50-day average: 7.90
200-day average: 5.78
52-week change: +75.50%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 37.2
vs 50-day SMA: −10.54%
vs 200-day SMA: +22.36%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▼ below
ATR (14) % of price: 6.82%
Realised vol (20d, ann.): 55.7%
From 52-week high: −21.05%
From 52-week low: +89.07%

ANR

Analyst Consensus

4 analysts

Consensus

Strong buy

1.00 on a 1 (strong buy) – 5 (sell) scale

Mean target

9.75

+37.52% implied

Low 7.00Median 9.00High 14.00

Recommendation trend

Now5 / 0 / 0
1m ago5 / 0 / 0
2m ago

DES

About SOPHiA GENETICS SA

Yahoo Finance profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom and a collaboration with AstraZeneca to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies. The company was incorporated in 2011 and is based in Rolle, Switzerland.

Sector: Healthcare
Industry: Health Information Services
Employees: 415
Headquarters: Rolle, Switzerland
Website: sophiagenetics.com
Officers: Dr. Jurgi Camblong M.B.A., Ph.D. Co-Founder & Executive Chairman
Mr. Ross Jordan Muken B.Sc. CEO & Director
Mr. George A. Cardoza M.B.A. Executive VP & CFO

SEAS

Seasonality · SOPH

2021–2026 · monthly returns

Strongest month Mar +10.15%Weakest month May −10.81%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	12.4	-14.3	10.0	5.5	-3.3	14.3	-1.7	48.1	-0.2	-15.4			+51.8%
2025	14.0	4.9	-9.5	-8.1	-1.6	3.3	1.0	10.5	37.6	5.0	-1.6	-5.1	+52.1%
2024	-2.5	8.9	-1.4	3.4	-2.2	-8.2	-3.9	-12.7	-4.9	-1.9	-4.7	-10.0	−34.8%
2023	45.6	-13.3	91.2	-2.6	-4.8	-2.8	-15.2	-35.8	4.3	45.0	8.9	17.2	+128.6%
2022	-17.0	9.4	-39.6	-16.8	-34.7	-13.8	-4.7	-4.6	-20.1	-16.3	5.0	-10.8	−85.4%
2021								26.3	-11.3	-19.1	-1.5	0.9	−9.9%

INSD

Insider Activity · SOPH

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

238.6K shares

Sells, 6 months

740.1K shares

Net shares

−501.4K

Net change in insider shares

−8.10%

Date	Insider	Transaction	Shares	Value
Oct 4, 2026	Cardoza George A.Chief Financial Officer	Sale at price 8.10 per share.	1.6K	$12.90K
Oct 4, 2026	Xu ZhenyuOfficer	Sale at price 8.12 per share.	7.4K	$60.08K
Oct 4, 2026	Verma AbhimanyuChief Technology Officer	Sale at price 8.12 per share.	5.3K	$42.93K
Oct 4, 2026	Camblong JurgiOfficer and Director	Sale at price 8.13 per share.	40.2K	$326.53K
Oct 4, 2026	Van Well Daan Guido MariaOfficer	Sale at price 8.12 per share.	6.2K	$50.10K
Oct 4, 2026	Menu PhilippeOfficer	Sale at price 8.13 per share.	7.4K	$60.10K
Oct 4, 2026	Valente ManuelaOfficer	Sale at price 8.13 per share.	4.2K	$34.49K
Oct 4, 2026	Muken Ross JChief Executive Officer	Sale at price 8.13 per share.	9.8K	$79.97K
Oct 4, 2026	Puylaert KevinOfficer	Sale at price 7.92 - 8.06 per share.	216	$1.74K
Sep 20, 2026	Cardoza George A.Chief Financial Officer	Sale at price 8.33 per share.	774	$6.45K
Sep 20, 2026	Muken Ross JChief Executive Officer	Sale at price 8.33 per share.	422	$3.52K
Sep 13, 2026	Xu ZhenyuOfficer	Sale at price 7.88 per share.	4K	$31.54K
Sep 13, 2026	Menu PhilippeOfficer	Sale at price 7.88 per share.	5K	$39.42K
Sep 10, 2026	Van Well Daan Guido MariaOfficer	Sale at price 7.63 per share.	6.2K	$47.09K
Sep 9, 2026	Camblong JurgiOfficer and Director	Sale at price 7.66 per share.	8.5K	$65.12K
Sep 7, 2026	Hibbs Kathy LDirector	Sale at price 8.13 per share.	6.3K	$50.82K
Aug 26, 2026	Xu ZhenyuOfficer	Sale at price 8.91 per share.	10K	$89.10K
Aug 24, 2026	Hibbs Kathy LDirector	Sale at price 8.68 per share.	6.3K	$54.23K
Aug 24, 2026	Menu PhilippeOfficer	Sale at price 8.68 per share.	5K	$43.40K
Aug 23, 2026	Verma AbhimanyuChief Technology Officer	Sale at price 8.20 - 8.80 per share.	10K	$85.00K

13F

Investors Holding SOPH

latest 13F filings of 29 followed managers

Investors holding SOPH
Investor	Value	Of portfolio	Shares	Change	Quarter
Akre Capital Management · Chuck Akre	$21.5M	0.42%	3.72M	—	Q2 2026
Renaissance Technologies	$653.7K	0.00%	113.30K	+89%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

SOPH

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

SOPH

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About SOPHiA GENETICS SA

Seasonality · SOPH

Insider Activity · SOPH

Congress Trades · SOPH

Investors Holding SOPH

Investors Holding SOPH

Congress Trades · SOPH

Insider Activity · SOPH

Seasonality · SOPH

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About SOPHiA GENETICS SA

Financial Snapshot

Earnings & Dividends

News